Clinical Edge Journal Scan

Rheumatoid arthritis tied to increased risk of developing primary open-angle glaucoma


 

Key clinical point: Patients with seropositive rheumatoid arthritis (RA) were at a higher risk of developing primary open-angle glaucoma (POAG) compared with matched control participants, with risk being evident within 2 years after RA diagnosis and among patients aged 75 years.

Major finding: Compared with matched control participants, patients with incident RA were 1.44 times more likely to develop POAG (hazard ratio [HR] 1.44; 95% CI 1.13-1.84), which was predominantly observed within 2 years of RA diagnosis (HR 1.83; 95% CI 1.28-2.61) and in patients aged ≥75 years (HR 2.12;95% CI 1.34-3.35).

Study details: This was a retrospective, nationwide cohort study including 2049 patients with seropositive RA who were propensity score-matched with 8196 control participants without RA.

Disclosures: This study was partly supported by the publication fee from the Graduate School of Public Health, Yonsei University. No conflicts of interest were declared.

Source: Kim SH et al. Development of open-angle glaucoma in adults with seropositive rheumatoid arthritis in Korea. JAMA Netw Open. 2022;5(3):e223345 (Mar 21). Doi: 10.1001/jamanetworkopen.2022.3345

Recommended Reading

Curcumin supplementation may improve metabolic, inflammatory, and obesity markers in women with RA
MDedge Rheumatology
Severe obesity reduces responses to TNF inhibitors and non-TNF biologics to similar extent
MDedge Rheumatology
Clinical Edge Journal Scan Commentary: RA April 2022
MDedge Rheumatology
Children with RMDs not at high risk for severe COVID-19, study finds
MDedge Rheumatology
Restrictive, vegan-based diet linked to fewer RA symptoms
MDedge Rheumatology
RA: Dosage and timing of rituximab infusion influence response to COVID-19 vaccine
MDedge Rheumatology
Frailty is dynamic and responsive to treatment in early RA
MDedge Rheumatology
Elevated adipokine levels predict early death in RA
MDedge Rheumatology
Reasons for b/tsDMARD treatment interruptions in rheumatoid arthritis
MDedge Rheumatology
Controlling inflammation may not alleviate disability in all patients with RA
MDedge Rheumatology